Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS).
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis (OLTERMS)
A case of post-vaccination optic neuritis: coincidence or causative?
Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics.
Hatha Yoga and Executive Function: A Systematic Review.
Falls and physical activity in persons with multiple sclerosis.
Managed care aspects of managing multiple sclerosis.
Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability?
Determinants of central nervous system adult neurogenesis are sex, hormones, mouse strain, age, and brain region.
Reverse causality behind the association between reproductive history and MS.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist.
Glutamate gene polymorphisms predict brain volumes in multiple sclerosis.
Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.
Active Biotech's partner Teva initiates a laquinimod clinical trial in Huntington's disease
Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis.
Speech and pause characteristics in multiple sclerosis: A preliminary study of speakers with high and low neuropsychological test performance.
The role of B cells in the onset of the first demyelinating event of optic neuritis.
Changes of synapses in experimental autoimmune encephalomyelitis by using Fasudil.
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
Lack of response to rituximab therapy in patients with neuromyelitis optica: True non-responders or insufficient treatment?
Decade in review-multiple sclerosis: New drugs and personalized medicine for multiple sclerosis.
Seizures and multiple sclerosis in Chinese patients: A clinical and magnetic resonance imaging study.
Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned.
Impact of multiple sclerosis relapses on progression diminishes with time.
Pages
« first
‹ previous
…
223
224
225
226
227
228
229
230
231
…
next ›
last »